This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sushrut Kulkarni: Innovator in Respiratory Therapeutics
Introduction
Sushrut Kulkarni is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of respiratory therapeutics, particularly through his innovative work on metered dose inhalers.
Latest Patents
Kulkarni holds 1 patent for his invention titled "Metered dose inhalers of fluticasone or an ester thereof." This invention relates to a metered dose inhaler that comprises a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester. The inhaler is designed with a canister fitted with a metering valve, an actuator, and a dose counter. The invention also includes a process for preparing the pharmaceutical composition and its application in treating respiratory disorders such as asthma in subjects, including humans.
Career Highlights
Sushrut Kulkarni is currently employed at Glenmark Pharmaceuticals Limited, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective solutions for respiratory health.
Collaborations
Kulkarni collaborates with talented professionals in his field, including Julianne Berry and Rajesh Ankam. Their combined expertise contributes to the innovative projects at Glenmark Pharmaceuticals Limited.
Conclusion
Sushrut Kulkarni's contributions to respiratory therapeutics through his patented inventions highlight his commitment to improving patient care. His work exemplifies the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile